Sign In

Basic HIV Primary Care.

HIV Question Bank

Initial EvaluationQuestion 6/10

Questions in Topic

A 25-year-old cisgender man was recently diagnosed with HIV and he is now presenting for an initial clinic evaluation. Baseline laboratory studies show a CD4 count of 716 cells/mm3 and an HIV RNA of 56,550 copies/mL. An HIV drug resistance genotype is pending. Approximately 3 years ago, he briefly tried tenofovir DF-emtricitabine and then tenofovir alafenamide-emtricitabine for HIV preexposure prophylaxis (PrEP) but did not tolerate either regimen well. The plan is to start antiretroviral therapy with a regimen of dolutegravir-abacavir-lamivudine.

Which one of the following would be indicated as a baseline test for this individual?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 30th, 2023

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.